ArticleJournal of neurology2022

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patients.

Jordi Río et al.PubMed ↗Publisher ↗

No numbers read from the abstract.